Local application of capsaicin into the draining lymph nodes attenuates expression of adjuvant-induced arthritis

NeuroImmunoModulation

Volumn 7, Issue 3, 2000, Pages 115-125

  Lorton, Dianne ^a   Lubahn, Cheri ^a,b   Engan, Chad ^a   Schaller, Jill ^a   Felten, David L ^c   Bellinger, Denise L ^c  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant induced arthritis; Capsaicin; Neural immune interactions; Substance P

Indexed keywords

CAPSAICIN; MINERAL OIL; NEUROTOXIN; SUBSTANCE P;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HINDLIMB; IMMUNOCYTOCHEMISTRY; LYMPH NODE; LYMPHATIC DRAINAGE; MAST CELL DEGRANULATION; NONHUMAN; NONMYELINATED NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SCIATIC NERVE;

EID: 0034115822     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026429     Document Type: Article

References (83)

1. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI: Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-549.
2. Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA: Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 1985; 12: 406-411.
3. Levine JD, Dardick SJ, Basbaum AI, Scipio E: Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci 1985;5:1380-1386.
4. Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AL: Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986;6: 3423-3429.
5. Levine JD, Fye K, Heller P, Basbaum AI, Whiting-O'Keefe Q: Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol 1986; 13:1040-1043.
6. Levine JD, Goetzl EJ, Basbaum AI: Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides; in Rheumatic Disease Clinics of North America. Philadelphia, Saunders, 1991, vol 13, pp 369-383.
7. Bill A, Stjernschantz J, Mandahl A, Brodin E, Nilsson G: Substance P: Release on trigeminal stimulation, effects in the eye. Acta Physiol Scand 1979;101:371-373.
8. Foreman JC, Jordan CC, Piotrowski W: Interaction of neurotensin with substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol 1982;77:531-539.
9. Jansco N, Jansco-Gabor A, Szolcsanyi J: Direct evidence for direct neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31:138-151.
10. Lembeck F, Gamse R, Juan H: Substance P and sensory nerve endings; in von Euler US, Pernow B (eds): Substance P. 37th Noble Symposium, Stockholm, 1976. New York, Raven Press, 1977, p 169.
11. Lembeck F, Holzer P: Substance P as neurogenic mediator of antidromic vasodilation and neurogenic and neurogenic plasma extravasation. Naunyn-Schmiedebergs Arch Pharmacol 1979;310:175-183.
12. Schumacher HR Jr: Synovial membrane and fluid morphologic alterations in early rheumatoid arthritis: Microvascular injury and virus-like particles. Ann NY Acad Sci 1975; 256:39-64.
13. Fink T, Weihe E: Multiple neuropeptides supplying mammalian lymph nodes: Messenger candidates for sensory and autonomic neuroimmunomodulation? Neurosci Lett 1988;90: 39-44.
14. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985;135:755s-765s.
15. Popper P, Mantyh CR, Vigna SR, Magioos JE, Mantyh PW: The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes. Peptides 1988;9:257-267.
16. Geppetti P, Maggi CA, Zecchi-Orlandini S, Santicioli P, Meli A, Frilli S, Spillantini MG, Amenta F: Substance P-like immunoreactivity in capsaicin-sensitive structures of the rat thymus. Regul Pept 1987;18:321-329.
17. Lorton D, Bellinger DL, Felten SY, Felten DL: Substance P innervation of the rat thymus. Peptide 1990;11:1269-1275.
18. Lorton D, Bellinger DL, Felten SY, Felten DL: Substance P innervation of spleen in rats: Nerve fibers associate with lymphocytes and macrophages in specific compartments of the spleen. Brain Behav Immun 1991;5:29-40.
19. Bellinger L, Lorton D, Romano TD, Olschowka JA, Felten SY, Felten DL: Neuropeptide innervation of lymphoid organs. Ann NY Acad Sci 1990;594:17-33.
20. Felten SY, Felten DL: Innervation of lymphoid tissue; in Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology. New York, Academic Press, 1991, pp 27-69.
21. Bellinger DL, Felten SY, Coleman PD, Yeh P, Felten DL: Noradrenergic innervation and acetyl cholinesterase activity of lymph nodes in young adults and aging mice. Soc Neurosci Abstr 1985;11:663.
22. Tonkoff W: Zur Kenntnis der Nerven der Lymphdrüsen. Anat Anz 1899;16:456-459.
23. Novotny GEK: Ultrastructural analysis of lymph node innervation in the rat. Acta Anat 1988;133:57-61.
24. Novotny GEK, Kliche KO: Innervation of lymph nodes: A combined silver impregnation and electron-microscopic study. Acta Anat 1986;127:243-248.
25. Payan DG, Brewster DR, Goetzl EJ: Specific stimulation of human T lymphocytes by substance P. J Immunol 1983;131:1613-1615.
26. Stanisz AM, Befus D, Bienenstock J: Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986;136:152-156.
27. Scicchitano R, Biennenstock J, Stanisz AM: In vivo immunomodulation by the neuropeptide substance P. Immunology 1988;63:733-735.
28. Moore TC: Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology 1984;52:511-518.
29. Moore TC, Lachman PJ: Cyclic AMP reduces and cyclic GMP increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo. Immunology 1982;47:423-428.
30. Moore TC, Lami JL, Spruck CH: Substance P increases lymphocyte traffic and lymph flow through peripheral lymph nodes of sheep. Immunology 1989;67:109-114.
31. Goebeler M, Henseleit U, Roth J, Sorg C: Substance P and calcitonin gene-related peptide modulate leukocytes. Arch Dermatol Res 1994; 286:341-346.
32. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH: Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993;151:3274-3282.
33. Hartung HP, Wolters D, Toyka KV: Substance P: Binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 1986;136:3856-3863.
34. Hartung HP, Toyka KV: Activation of macrophages by substance P: Induction of oxidative burst and thromboxane release. Eur J Pharmacol 1983;89:301-305.
35. Lotz M, Vaughn JH, Carson DA: Effects of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218-1221.
36. Bar-Shavit Z, Goldman R, Stabinsky Y, Gottleib F, Fridkin M, Teichberg V, Blumberg S: Enhancement of phagocytosis - A newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980;94;1445-1451.
37. Pawlikowski M, Stepien H, Kunert-Radek J, Schally AV: Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun 1985;129: 52-55.
38. Payan DG, McGillis JP, Goetzl EJ: Neuroimmunology, in Dixon FJ, Austen KF, Hood L, Uhr JW (eds): Advances in Immunology, New York, Academic Press, 1986, pp 299-323.
39. Stanisz A, Scicchitano R, Dazin P, Bienenstock J, Payan DG: Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 1987;139:749-754.
40. Payan DG, Brewster DR, Goetzl EJ: Stercospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol 1984;133: 3260-3265.
41. Ruff MR, Wahl SM, Pert CB: Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985;6:107-111.
42. Okiji T, Jontel M, Belichenko P, Dahlgren U, Bergenholtz G, Dahlstrom A: Structural and functional association between substance P-and calcitonin gene-related peptide-immunoreactive nerves and accessory cells in the rat dental pulp. J Dental Res 1997;76:1818-1824.
43. Bulloch K, McEwen BS, Diwa A, Radojcic T, Hausman J, Baird S: The role of calcitonin gene-related peptide in mouse thymus revisited. Ann NY Acad Sci 1994;741:129-136.
44. Wang X, Fiscus RR, Yang L, Wu J, Fan S, Mathews HL: CGRP in the serum of endotoxin-treated rats suppresses lymphoproliferation. Brain Behav Immun 1994;8:282-292.
45. Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD: Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995;154:3056-3061.
46. Payan DG, Hess CA, Goetzl EJ: Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt44 lymphoblasts. Cell Immunol 1984;84:433-438.
47. Stanisz AM, Scicchitano R, Payan DG, Bienenstock J: In vitro studies of immunoregulation of substance P and somatostatin. Ann NY Acad Sci 1987;496:217-225.
48. Ainsworth A, Hall P, Wall PD, Allt G, MacKenzie ML, Gibson S, Polak JM: Effects of capsaicin applied locally to adult peripheral nerve. II. Anatomy and enzyme and peptide chemistry of peripheral nerve and spinal cord. Pain 1981;11:379-388.
49. Burnstock G, Evans B, Gannon FJ, Heath JW, James V: A new method of destroying adrenergic nerves in adult animals using guanethidine. Br J Pharmacol 1971;43:295-301.
50. Jensen-Holm J, Juul P: Ultrastructural changes in the rat superior cervical ganglion following prolonged guanethidine administration. Acta Pharmacol Toxicol 1971;30:308-320.
51. Buck SH, Burks TF: The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 1986;38:179-226.
52. Chung K, Klein CM, Coggeshall RE: The receptive part of the primary afferent axon is most vulnerable to systemic capsaicin in adult rats. Brain Res 1990;511:222-226.
53. Lai JP, Douglas SD, Ho WZ: Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998;86:80-86.
54. Nilsson G, Alving K, Ahlstedt S, Hokfelt T, Lundberg JM: Pcptidergic innervation of rat lymphoid tissue and lung: Relation to mast cells and sensitivity to capsaicin and immunization. Cell Tissue Res 1990;262:125-133.
55. Newbould BB: Lymphatic drainage and adjuvant-induced arthritis in rats. Ann NY Acad Sci 1964;45:375-383.
56. Newbould BB: Role of lymph nodes in adjuvant-induced arthritis in rats. Ann Rheum Dis 1964;23:391-396.
57. Pearson CM, Wood FD: Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am J Pathol 1963;42:73-95.
58. Ackerman NR, Rooks WH II, Shott L, Genant H, Maloney P, West E: Effects of naproxen on connective tissue changes in the adjuvant arthritis rat. Arthritis Rheum 1979;22:1365-1374.
59. Chahl LA, Ladd RJ: Local oedema and general excitation of cutaneous sensory receptors produced by electrical stimulation of the saphenous nerve in the rat. Pain 1976;2:25-34.
60. Denko CW, Petricevic M: Sympathetic or reflex footpad swelling due to crystal-induced inflammation in the opposite foot. Inflammation 1978;3:81-86.
61. Thompson M, Bywaters EGL. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962;21:370-377.
62. Glick EN: Asymmetrical rheumatoid arthritis after poliomyelitis. Br Med J 1967;iii:26-29.
63. Colpaert FC, Donnerer J, Lembeck F: Effects of capsaicin on inflammation and on substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci 1983;32:1827-1834.
64. Noguchi K, Deleon M, Nahin RL, Senba E, Ruda MA: Quantification of axotomy-induced alteration of neuropeptide mRNA in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment. J Neurosci Res 1993; 35:54-66.
65. Pohl M, Benoliel JJ, Bourgoin S, Lombard MC, Mauborgen A, Taquet H, Carayon A, Besson JM, Cesselin, F, Hamon M: Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A(1-8)-like materials in the spinal cord and dorsal cord and dorsal root ganglia of adult rats: Effects of dorsal rhizotomy and neonatal capsaicin. J Neurochem 1990;55: 1122-1130.
66. Kashiba H, Ueda Y, Senba E: Coexpression of preprotachykinin-A, alpha-calcitonin gene-related peptide, somatostatin and neurotrophin receptor family messenger RNAs in rat dorsal root ganglion neurons. Neuroscience 1996;70: 179-189.
67. McGillis JP, Humphreys S, Reid S: Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes. J Immunol 1991;147:3482-3489.
68. Umeda Y, Arisawa M: Characterization of the calcitonin gene-related peptide receptor in mouse T lymphocytes. Neuropeptides 1989;14: 237-242.
69. Vignery A, Raymond MJ, Qian HY, Wang F, Rosenzweig SA: Multinucleated rat alveolar macrophages express functional receptors for calcitonin. Am J Physiol 1991;261:F1026-F1032.
70. Payan DG, Goetzl EJ: Dual roles of substance P: Modulator of immune and neuroendocrine functions. Ann NY Acad Sci 1987;512:465-475.
71. Hanley MR, Lee CM, Jones LM, Michel RH: Similar effects of substance P and related peptides on salivation and on phosphatidylinositol turnover in rat salivary glands. Mol Pharmacol 1980;18:78-83.
72. Wang F, Millet I, Bottomly K, Vignery A: Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J Biol Chem 1992;267:1052-1057.
73. Wang X, Fiscus RR, Yang L, Mathews HL: Suppression of the functional activity of of IL-2-activated lymphocytes by CGRP. Cell Immunol 1995;162:105-113.
74. Vishwanath R, Mukherjee R: Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J Neuroimmunol 1996;71:163-171.
75. Nakagawa N, Iwamoto I, Yoshida S: Effect of substance P on the expression of an adhesion molecule ICAM-1 in human vascular endothelial cells. Regul Pept 1993;46:223-224.
76. Nakagawa N, Sano H, Iwamoto I: Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 1995;16:721-725.
77. Matis WL, Lavker RM, Murphy GF: Substance P induces the expression of an endothelial leukocyte. J Invest Dermatol 1990;94:492-495.
78. Bulloch K, McEwen BS, Diwa A, Baird S: Relationship between dehydroepiandrosterone and calcitonin gene-related peptide in the mouse thymus. Am J Physiol 1995;2689:E168-E173.
79. Theoharides TC, Douglas WE: Mast cell histamine secretion in response to somatostatin analogues: Structural considerations. Eur J Pharmacol 1981;73:131-136.
80. Goetzl EJ, Payan DG: Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 1984;133:3255-3259.
81. Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D: Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release. J Immunol 1985;135:1331-1337.
82. Torii H, Hosoi J, Beissert S, Xu S, Fox RE, Asahina A, Takashima A, Rook RH, Granstein RD: Regulation of cytokine expression in macrophages and the Langerhans cell-like XS52 by calcitonin gene-related peptide. J Leukoc Biol 1997;61:216-223.
83. Fox RE, Kubin M, Cassin M, Niu Z, Hosoi J, Torii H, Granstein RD, Trinchieri G, Rook AH: Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: Effects on B7, interleukin 10 and interleukin 12. J Invest Dermatol 1997;108:43-48.